Clinical trials for generics proposed

EVEN AS INDIAN drug-makers have heaved a sigh of relief with the United States' decision to shelve the plan to extend the tariff hikes to generic medicines, a key change is in the offing in domestic regulations that will spell trouble for them.

- MANU KAUSHIK

The country's drug regulator - Central Drugs Standard Control Organisation (CDSCO) - has proposed to close the easy route for pharma